Should I buy Veeva Systems (VEEV) stock or is it too late?

Veeva Systems · Health Care · price $282
Logo Veeva SystemsSee the full Veeva Systems (VEEV) profile
⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: BMO Capital73% of its targets hit on this sector (239 calls tested). It aims for $175 (-38 %), call made on June 5, 2026, maturing on June 5, 2027 (84 d ago).

The 15 reliable analysts $270-4.3 %
The 5 other firms $262-7.1 %
How to read it: the 15 reliable firms are not filtered by optimism — 3 aim above the price, 12 below, hence their $270 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Veeva Systems

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.
Firm% rightGain vs sectorCallsAims for
Canaccord Genuity88 %+52.6 %8$220 -22%
Guggenheim67 %+40.5 %6$276 -2%
Stifel67 %+36.2 %18$275 -3%
Morgan Stanley77 %+32.5 %31$215 -24%
Baird62 %+23.9 %16$260 -8%
Piper Sandler64 %+16.1 %25$235 -17%
Goldman Sachs83 %+13.5 %6$165 -42%
Needham56 %+8.6 %25$270 -4%
In short — Should you invest in Veeva Systems? Is it too late, still worth it? Analysts are fairly positive (65% buy, median target $266, i.e. -6%). But the valuation is stretched (P/E ~46), it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

  • 65% of analysts rate it a buy (Buy consensus, 20 ratings) — a sign of market conviction.

⚠️ Reasons to hesitate

  • Even the most reliable firm on VEEV, Canaccord Genuity (88% hit rate, 8 scored calls), only targets $220 (call made on June 4, 2026, maturing on June 4, 2027) (-22%) in its most recent call, and $280 (call made on November 21, 2025, maturing on November 21, 2026) (-1%) in the one coming due soonest. The stock may already have run past its target.
  • The consensus is not unanimous: of 20 ratings, 6 are neutral and 1 is a sell.
  • Limited upside: the median target is only -6% from the current price.
  • High valuation (P/E ~46): strong growth is already "priced in", leaving little room for error.
  • A 12-month target is not a guaranteed path: the price can fall in the meantime.
  • No dividend: your return depends only on price appreciation.

The analyst consensus on VEEV

Median target $266 (-6%) · 20 ratings · Buy consensus

Strong Buy00%
Buy1365%
Hold630%
Sell15%
Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Veeva Systems now?

We won't decide for you. The facts: 65% of analysts rate it a buy, median target $266 (-6%), and Canaccord Genuity (most reliable on VEEV, 88%) targets $220. Weigh that against valuation (P/E ~46). This is not personalized advice.

Is it too late to invest in Veeva Systems?

The stated upside is small: the median target ($266) sits just -6% from the price ($282) (most reliable on VEEV: Canaccord Genuity, 88%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Veeva Systems still worth investing in?

It depends on the gap between the price ($282) and its estimated value: analysts target $266 on median (-6%), with 65% buys (most reliable on VEEV: Canaccord Genuity, 88%). Cross-check with their real reliability on VEEV and the cautions above. Information, not advice.

What's the main risk in buying VEEV?

Even the most reliable firm on VEEV, Canaccord Genuity (88% hit rate, 8 scored calls), only targets $220 (call made on June 4, 2026, maturing on June 4, 2027) (-22%) in its most recent call, and $280 (call made on November 21, 2025, maturing on November 21, 2026) (-1%) in the one coming due soonest. The stock may already have run past its target.

→ Go deeper: the full Veeva Systems profile (consensus, analyst reliability, price target, performance).

JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)